Therapy Areas: Central Nervous System
1 September 2022 - United States-based Genzyme announced on Wednesday, that the United States Food and Drug Administration has approved the company's Xenpozyme (Olipudase alfa) for intravenous in...
25 August 2022 - Alpha Biopharma, a China-based developer of innovative drugs, announced on Wednesday that it has completed last patient last visit (LPLV) in its international, multicentre EVEREST pha...
24 August 2022 - - US-based gene therapy company Lacerta Therapeutics, a specialist in the development of adeno-associated virus technologies for the treatment of central nervous system diseases, has ...
23 August 2022 - - US-based Gate Neurosciences has launched to develop its next-generation therapeutics addressing synaptic dysfunction in patients suffering from central nervous system disorders, the...
23 August 2022 - Brii Biosciences Limited (stock code: 2137.HK), a China-based multi-national company that develops innovative therapies for diseases with significant unmet medical needs and large pub...
22 August 2022 - - Canada-based pharmaceutical company Alpha Cognition Inc. (TSX Venture: ACOG) (OTCQB: ACOGF) has received positive results from a bioequivalence study with ALPHA-1062, a proprietary,...
Related Headlines